Search Results

Getting Past HSC Security: Cyclosporine H Gives Lentiviruses an Entry Pass.

• Authors : Bauer DE; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Subjects: Gene Editing*; Lentivirus/Lentivirus/Lentivirus/*genetics; Cyclosporine

• Source: Cell stem cell [Cell Stem Cell] 2018 Dec 06; Vol. 23 (6), pp. 775-776.Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print Cited Medium:

Record details

Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface.

• Authors : Goldstone DC; Division of Molecular Structure, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London, UK.; Yap MW

Subjects: Evolution, Molecular*; Capsid Proteins/Capsid Proteins/Capsid Proteins/*chemistry ; Cyclophilin A/Cyclophilin A/Cyclophilin A/*metabolism

• Source: Cell host & microbe [Cell Host Microbe] 2010 Sep 16; Vol. 8 (3), pp. 248-59.Publisher: Cell Press Country of Publication: United States NLM ID: 101302316 Publication Model: Print Cited Medium:

Record details

A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade.

• Authors : Agudo J; Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York City, NY 10028, USA.; Ruzo A

Subjects: Hepatocytes/Hepatocytes/Hepatocytes/*metabolism ; Lentivirus/Lentivirus/Lentivirus/*immunology ; Toll-Like Receptors/Toll-Like Receptors/Toll-Like Receptors/*metabolism

• Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2012 Dec; Vol. 20 (12), pp. 2257-67. Date of Electronic Publication: 2012 Aug 07.Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited

Record details

The Ability of Primate Lentiviruses to Degrade the Monocyte Restriction Factor SAMHD1 Preceded the Birth of the Viral Accessory Protein Vpx.

• Authors : Lim, Efrem S.; Fregoso, Oliver I.; McCoy, Connor O.

Subjects: LENTIVIRUSES; PROTEOLYSIS; VIRAL proteins

• Source: Cell Host & Microbe; Feb2012, Vol. 11 Issue 2, p194-204, 11p

Record details

Immune Evasion and Counteraction of Restriction Factors by HIV-1 and Other Primate Lentiviruses.

• Authors : Kirchhoff, Frank

Subjects: HOST-virus relationships; LENTIVIRUSES; MICROBIAL virulence

• Source: Cell Host & Microbe; Jul2010, Vol. 8 Issue 1, p55-67, 13p

Record details

The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.

• Authors : Heigele, Anke; Kmiec, Dorota; Regensburger, Kerstin

• Source: Cell Host & Microbe; Sep2016, Vol. 20 Issue 3, p381-391, 11p

Record details

Construction and Screening of a Lentiviral Secretome Library.

• Authors : Liu, Tao¹ ; Jia, Panpan¹; Ma, Huailei¹

Subjects: *LENTIVIRUSES; *OPEN reading frames (Genetics); *NUCLEOTIDE sequencing

• Source: Cell Chemical Biology. Jun2017, Vol. 24 Issue 6, p767-771.e3. 1p.

Record details

WNT-SHH Antagonism Specifies and Expands Stem Cells prior to Niche Formation.

• Authors : Ouspenskaia, Tamara¹; Matos, Irina¹; Mertz, Aaron F.¹

Subjects: *LENTIVIRUSES; *WNT genes; *STEM cells

• Source: Cell. Jan2016, Vol. 164 Issue 1/2, p156-169. 14p.

Record details

Protocol for generating human CAR-engineered macrophages by Vpx-containing lentivirus.

• Authors : Gao Y; RocRock Biotechnology (Suzhou), Suzhou 215000, China.; Fang X

Subjects: Macrophages*/Macrophages*/Macrophages*/metabolism ; Macrophages*/Macrophages*/Macrophages*/cytology ; Lentivirus*/Lentivirus*/Lentivirus*/genetics

• Source: STAR protocols [STAR Protoc] 2024 Dec 20; Vol. 5 (4), pp. 103350. Date of Electronic Publication: 2024 Sep 28.Publisher: Cell Press Country of Publication: United States NLM ID: 101769501 Publication Model: Print-Electronic Cited

Record details

Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations.

• Authors : Yoon JK; AVROBIO, Inc., Cambridge, MA 02139, USA.; Schindler JW

Subjects: Glycogen Storage Disease Type II*/Glycogen Storage Disease Type II*/Glycogen Storage Disease Type II*/therapy ; Glycogen Storage Disease Type II*/Glycogen Storage Disease Type II*/Glycogen Storage Disease Type II*/genetics ; Lentivirus*/Lentivirus*/Lentivirus*/genetics

• Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Nov 06; Vol. 32 (11), pp. 3847-3864. Date of Electronic Publication: 2024 Sep 17.Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited

Record details